糖抗原125(CA125)多克隆抗体

Polyclonal Antibody to Carbohydrate Antigen 125 (CA125)

MUC16; Cancer Antigen 125; Mucin 16,Cell Surface Associated; Ovarian Cancer-Related Tumor Marker CA125; Ovarian Carcinoma Antigen CA125

  • 糖抗原125(CA125)多克隆抗体 产品包装(模拟)
  • 糖抗原125(CA125)多克隆抗体 产品包装(模拟)
  • 糖抗原125(CA125)多克隆抗体 DAB staining on IHC-P; Samples: Mouse Uterus Tissue; Primary Ab: 20μg/ml Rabbit Anti-Mouse CA125 Antibody Second Ab: 2µg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • PAA154Mu01.jpg Figure. Western Blot; Sample: Recombinant CA125, Mouse.
  • 糖抗原125(CA125)多克隆抗体 Figure. Western Blot; Sample: Lane1: Human Hela Tissue; Lane2: Mouse Ovary Tissue.
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

特异性

该抗体是针对CA125的兔多克隆抗体。在免疫组织化学染色和免疫印迹实验中能识别CA125。

用法

Western blotting: 0.5-2µg/mL;
Immunohistochemistry: 5-20µg/mL;
Immunocytochemistry: 5-20µg/mL;
Optimal working dilutions must be determined by end user.

储存

经常使用则4°C保存。-20°C保存不超过两年。避免反复冻融。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

赠品

相关产品

编号 适用物种:Mus musculus (Mouse,小鼠) 应用(仅供研究使用,不用于临床诊断!)
RPA154Mu01 糖抗原125(CA125)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
RPA154Mu02 糖抗原125(CA125)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAA154Mu01 糖抗原125(CA125)多克隆抗体 WB; IHC; ICC; IP.
PAA154Mu02 糖抗原125(CA125)多克隆抗体 WB; IHC; ICC; IP.
LAA154Mu71 糖抗原125(CA125)多克隆抗体(生物素标记) WB; IHC; ICC.
SEA154Mu 糖抗原125(CA125)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA154Mu 糖抗原125(CA125)等多因子检测试剂盒(流式荧光发光法) FLIA Kit for Antigen Detection.

参考文献

杂志 参考文献
PLoS One Selective Blocking of TNF Receptor 1 Attenuates Peritoneal Dialysis Fluid Induced Inflammation of the Peritoneum in Mice. [pubmed:27755542]
Tumor Biology KPNA2 is a potential diagnostic serum biomarker for epithelial ovarian cancer and correlates with poor prognosis [pubmed:28651492]
Oncotarget Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer [Pubmed:29484129]
Prognostic value of STC1 expression in ovarian cancer []
American Journal of Translational Research Synergistic effect of Tripterygium glycosides and cisplatin on drug-resistant human epithelial ovarian cancer via ILK/GSK3β/Slug signal pathway [Pubmed:35422913]
留言咨询